Thermo-triggered drug release from actively targeting polymer micelles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapy

Background:

• Effective cancer therapy requires precise drug delivery to target sites at optimal concentrations.
• Controlling drug release kinetics remains a significant challenge in chemotherapy.

Purpose of the Study:

• To develop thermo-responsive nanocarriers for controlled release of anticancer drugs.
• To enhance drug delivery efficiency and therapeutic outcomes in cancer treatment.

Main Methods:

• Synthesized Pluronic F127-poly(d,l-lactic acid) (FP) copolymer micelles.
• Decorated FP micelles with folate (FA) for active targeting.
• Investigated drug release profiles at different temperatures (37 °C vs. 40 °C).
• Evaluated cytocompatibility and cellular uptake using NIH 3T3 and HeLa cell lines.

Main Results:

• FP100 micelles exhibited a critical solution temperature of 39.2 °C, near body temperature.
• Minimal drug (DOX) release at 37 °C, with rapid release upon mild heating to 40 °C.
• FA-decorated FP100 micelles showed enhanced cellular uptake and cytotoxicity in folate receptor-overexpressing HeLa cells.
• Significantly increased cytotoxicity of DOX-loaded FA-FP100 micelles against HeLa cells under hyperthermia (40 °C).

Conclusions:

• Developed temperature-sensitive FP micelles offer precise control over drug release for cancer therapy.
• Folate decoration enhances targeted delivery and efficacy against cancer cells.
• These nanocarriers show great potential as advanced drug delivery systems for improved cancer treatment.